clinical
Kallisio Expands Clinical Use of Stentra
Pilot-to-commercial conversion follows an observational case series showing zero missed treatment days and favorable toxicity and tolerance signals in head and neck radiotherapy. Kallisio, a leader in patient-specific solutions for radiation oncology, recently announced Texas Cancer Institute (TCI) has transitioned from a pilot evaluation to clinical use of Stentra™ for precision head and neck cancer […] The post Kallisio Expands Clinical Use of Stentra appeared first on Dentistry Today.
By Dentistry Today ·
Pilot-to-commercial conversion follows an observational case series showing zero missed treatment days and favorable toxicity and tolerance signals in head and neck radiotherapy. Kallisio, a leader in patient-specific solutions for radiation oncology, recently announced Texas Cancer Institute (TCI) has transitioned from a pilot evaluation to clinical use of Stentra™ for precision head and neck cancer […]
The post Kallisio Expands Clinical Use of Stentra appeared first on Dentistry Today.